Invention Grant
- Patent Title: Factor VII composition having a substantially homogenous isoelectric point
-
Application No.: US16868803Application Date: 2020-05-07
-
Publication No.: US11254920B2Publication Date: 2022-02-22
- Inventor: Guillaume Chevreux
- Applicant: Laboratoire Francais du Fractionnement et des Biotechnologies
- Applicant Address: FR Les Ulis
- Assignee: Laboratoire Francais du Fractionnement et des Biotechnologies
- Current Assignee: Laboratoire Francais du Fractionnement et des Biotechnologies
- Current Assignee Address: FR Les Ulis
- Agency: Potomac Law Group, PLLC
- Agent Rouget F. Henschel
- Priority: FR13/55403 20130611
- Main IPC: A61K35/14
- IPC: A61K35/14 ; A61K38/48 ; C07K1/00 ; C07K16/00 ; C07K17/00 ; A61K38/43 ; A61K38/57 ; C07K14/745 ; A61K38/36 ; A61P7/02 ; A61K38/00 ; A61P7/00 ; C12N9/64 ; A01K67/027
Abstract:
The present invention relates to a factor VII composition having a substantially homogeneous isoelectric point and to a method for formulating such a composition. The present invention also relates to the therapeutic use of a factor VII composition having a substantially homogeneous isoelectric point.
Public/Granted literature
- US20200270596A1 Factor VII Composition Having a Substantially Homogenous Isoelectric Point Public/Granted day:2020-08-27
Information query
IPC分类:
